Načítá se...
The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer
The integration of targeted agents to standard cytotoxic regimens has improved outcomes for patients with colorectal cancer (CRC) over recent years; however this malignancy remains the second leading cause of cancer mortality in industrialized countries. Small molecule inhibitors of heat shock prote...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4101249/ https://ncbi.nlm.nih.gov/pubmed/24682747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-014-0095-4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|